CH661867A5 - Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin. - Google Patents

Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin. Download PDF

Info

Publication number
CH661867A5
CH661867A5 CH2838/84A CH283884A CH661867A5 CH 661867 A5 CH661867 A5 CH 661867A5 CH 2838/84 A CH2838/84 A CH 2838/84A CH 283884 A CH283884 A CH 283884A CH 661867 A5 CH661867 A5 CH 661867A5
Authority
CH
Switzerland
Prior art keywords
preparation
human
diltiazem
pharmaceutically acceptable
medicine
Prior art date
Application number
CH2838/84A
Other languages
German (de)
English (en)
Inventor
Kohki Takashima
Shuji Nitta
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of CH661867A5 publication Critical patent/CH661867A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
CH2838/84A 1983-06-10 1984-06-12 Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin. CH661867A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58104691A JPS59231018A (ja) 1983-06-10 1983-06-10 抗脂血剤

Publications (1)

Publication Number Publication Date
CH661867A5 true CH661867A5 (de) 1987-08-31

Family

ID=14387491

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2838/84A CH661867A5 (de) 1983-06-10 1984-06-12 Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin.

Country Status (12)

Country Link
JP (1) JPS59231018A (fr)
BE (1) BE899867A (fr)
CH (1) CH661867A5 (fr)
DE (1) DE3419425A1 (fr)
DK (1) DK164021C (fr)
FR (1) FR2547730B1 (fr)
GB (1) GB2141027B (fr)
HK (1) HK45489A (fr)
IT (1) IT1196710B (fr)
NL (1) NL8401793A (fr)
SE (1) SE465352B (fr)
SG (1) SG21089G (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389446B (de) * 1987-10-08 1989-12-11 Tanabe Seiyaku Co Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels
AT390880B (de) * 1986-05-23 1990-07-10 Tanabe Seiyaku Co Pharmazeutische verwendung einer 8-chlorobenzothiazepinverbindung

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
GB9423172D0 (en) * 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS58208222A (ja) * 1982-05-28 1983-12-03 Japan Found Cancer 抗腫瘍剤効果増強剤
JPS5970611A (ja) * 1982-10-15 1984-04-21 Tanabe Seiyaku Co Ltd 医薬組成物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT390880B (de) * 1986-05-23 1990-07-10 Tanabe Seiyaku Co Pharmazeutische verwendung einer 8-chlorobenzothiazepinverbindung
AT389446B (de) * 1987-10-08 1989-12-11 Tanabe Seiyaku Co Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels

Also Published As

Publication number Publication date
SE8403042D0 (sv) 1984-06-06
DE3419425A1 (de) 1984-12-13
DK164021C (da) 1992-09-28
SG21089G (en) 1990-01-26
NL8401793A (nl) 1985-01-02
GB2141027B (en) 1986-10-22
GB8414498D0 (en) 1984-07-11
IT8467596A1 (it) 1985-12-08
FR2547730B1 (fr) 1987-11-13
DK164021B (da) 1992-05-04
DE3419425C2 (fr) 1989-06-08
DK284084A (da) 1984-12-11
IT8467596A0 (it) 1984-06-08
SE8403042L (sv) 1984-12-11
SE465352B (sv) 1991-09-02
BE899867A (fr) 1984-10-01
HK45489A (en) 1989-06-16
IT1196710B (it) 1988-11-25
DK284084D0 (da) 1984-06-08
GB2141027A (en) 1984-12-12
JPS59231018A (ja) 1984-12-25
FR2547730A1 (fr) 1984-12-28
JPS6317810B2 (fr) 1988-04-15

Similar Documents

Publication Publication Date Title
EP0185210B1 (fr) Utilisation de dérivés dipeptidiques pour la préparation de médicaments pour le traitement des malades atteints de sclérose latérale amyotrophique
EP0529500B1 (fr) Médicament pour le traitement de réactions de rejet lors de transplantations d'organes
DE3319347C2 (fr)
EP0607776A2 (fr) Utilisation de leflunomid pour inhiber le facteur alpha de necrose tumorale
CH661867A5 (de) Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin.
DE2335215A1 (de) Arzneimittel zur foerderung der proteinsynthese und zur unterdrueckung der harnstoffbildung
DE2726392A1 (de) Mittel zur bekaempfung der venoesen thrombose
DE4024885A1 (de) Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE60200160T2 (de) Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen
DE3141970C2 (fr)
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
EP0005732B1 (fr) Utilisation de amino-2-oxazolo-ou amino-2-thiazolo[5,4-d]azépines ainsi que leurs sels d'addition acides pour la préparation d'un médicament pour le traitement de Angina Pectoris
DE2209526C3 (de) Coronartherapeutlkum in Form von Gelatine-BeiBkapseln
DE2728589A1 (de) Verwendung von 2-(2,2-disubstituierten)-aethylimidazolinen bei der bekaempfung von diabetes
DE3212909C2 (fr)
DE3714322C2 (de) Prophylaktisches und therapeutisches Mittel für hepatische Krankheiten
EP0604830B1 (fr) Utilisation d'au moins un antagoniste du PAF dans la fabrication d'un médicament pour le traitement ou la prévention de l'hyperinsulinisme
DE3213579C2 (fr)
WO1993024130A1 (fr) Medicament contenant du (-)-metrifonate
DE69630561T2 (de) Verwendung von 4-Amino-6-hydroxypyrazolo[3,4-d]pyrimidin zur Herstellung eines blutdrucksenkenden Mittels
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DE2636328A1 (de) Arzneimittel
DE2308240C3 (de) Oral oder parenteral verabreichbares antihypertensives Mittel
DE2810051A1 (de) Zubereitung fuer die behandlung von asthma
DE2755018A1 (de) Mittel zur behandlung cardiovasculaerer stoerungen bei saeugetieren

Legal Events

Date Code Title Description
PL Patent ceased